4.2 Review

Clean Bioprinting - Fabrication of 3D Organ Models Devoid of Animal Components

期刊

出版社

SPEKTRUM AKADEMISCHER VERLAG-SPRINGER-VERLAG GMBH
DOI: 10.14573/altex.2009151

关键词

-

资金

  1. Herbert-Stiller Prize - society Doctors Against Animal Experiments
  2. Stiftung zur Forderung der Erforschung von Ersatz-und Erganzungsmethoden zur Einschrankung von Tierversuchen (set)
  3. Bundesinstitut fur Risikoforschung [1328-568]
  4. Landesamt fur Gesundheit und Soziales (LaGeSo) Berlin together with Die forschenden Pharma-Unternehmen (vfa)
  5. TU [3-3333115-02-01]
  6. TU Berlin

向作者/读者索取更多资源

Bioprinting technology enables precise positioning of living cells in bio-materials to fabricate tissues and organs, with the potential for organ transplantation and research. However, current bioprinting procedures often involve animal-derived components, prompting the development of strategies to replace these with synthetic or plant-based materials. Aiming for animal component-free bioprinting, known as clean bioprinting, involves adapting cells to FBS-free media and using bioinks of human origin.
Bioprinting is a rapidly developing technology that enables the exact positioning of living cells embedded in bio-materials in precise spatial arrangements to fabricate engineered tissues and organs. While the ultimate goal of bioprinting approaches is to produce organs for transplantation purposes, bioprinted organ models also hold great potential for research purposes to serve as alternatives to animal experiments. By using human cells, humanized organ models can be generated that may produce more relevant results for human (patho-)physiology than animal models. However, standard bioprinting procedures currently use numerous hidden animal components. Virtually all studies published in the field to date make use of cells grown in media with fetal bovine serum (FBS). In addition, Matrigel, the extracellular matrix (ECM) harvested from Engelbreth-Holm-Swarm sarcoma grown in mice, is widely employed to cultivate stem cells and 3D organ models. Finally, most bioinks currently in use contain gelatin or comparable animal components to improve cell viability and adhesion. The present review will give an introduction to the potential of bioprinting to fabricate 3D models that may be substituted for animal experiments and will go on to describe strategies to replace animal components currently included in standard procedures of bioprinting. These approaches comprise the adaptation of cells to FBS-free media, the use of bioinks composed of synthetic or plant material, and the replacement of animal ingredients by materials of human origin. We propose denoting bioprinting strategies devoid of animal components as clean bioprinting.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.2
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据